Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature

被引:0
作者
G. Boleto
J.-M. Perotin
J.-P. Eschard
J.-H. Salmon
机构
[1] Reims University Hospitals,Department of Rheumatology
[2] Reims University Hospitals,Department of Respiratory Medicine
[3] INSERM 903,Faculty of Medicine
[4] University of Reims-Champagne-Ardenne,undefined
[5] EA 3797,undefined
[6] REIMS,undefined
来源
Rheumatology International | 2017年 / 37卷
关键词
Antisynthetase syndrome; Anti-Jo1 antibodies; Malignancy; Positron emission tomography;
D O I
暂无
中图分类号
学科分类号
摘要
Antisynthetase syndrome is a heterogeneous idiopathic inflammatory myopathy. Anti-Jo1 is the most common antibody found in this condition. Dermatomyositis is known to be associated with malignancy, but the association between antisynthetase syndrome and malignancy is not clearly established. We report a case of an association of squamous cell carcinoma of the lung and anti-Jo1 antisynthetase syndrome. A 67-year-old man presented with polyarthritis, muscle weakness of the pelvic girdle, “mechanic’s hands,” and weight loss. A diagnosis of antisynthetase syndrome was considered based on the clinical features and the presence of anti-Jo1 antibodies. Positron emission tomography was performed because of weight loss and revealed a pulmonary hypermetabolic lesion. Histological findings revealed squamous cell carcinoma. The patient underwent lobectomy and is currently free of symptoms with regular monitoring. This unusual presentation of squamous cell carcinoma of the lung illustrates the need of a systematic approach to the diagnosis of antisynthetase syndrome. Positron emission tomography can be a useful imaging modality in the diagnosis of paraneoplastic syndromes associated with antisynthetase syndrome especially in the presence of warning signs/symptoms.
引用
收藏
页码:1203 / 1206
页数:3
相关论文
共 129 条
[1]  
Hervier B(2010)Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases Rheumatology 49 972-976
[2]  
Wallaert B(2013)Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome Arthritis Care Res 65 800-808
[3]  
Hachulla E(2002)Malignancy in patients with inflammatory myopathy Curr Rheumatol Rep 4 415-426
[4]  
Adoue D(2012)Hematological malignancy associated with polymyositis and dermatomyositis Autoimmun Rev 11 615-620
[5]  
Lauque D(2001)Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study The Lancet 357 96-100
[6]  
Audrain M(2003)Antisynthetase syndrome Jt Bone Spine 70 161-168
[7]  
Marie I(2012)Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity Autoimmun Rev 12 210-217
[8]  
Josse S(2012)Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody Semin Arthritis Rheum 41 890-899
[9]  
Hatron PY(1992)et al [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma] Nihon Kyōbu Shikkan Gakkai Zasshi 30 1858-1863
[10]  
Dominique S(2004)Jo-1 syndrome with associated poorly differentiated adenocarcinoma Rheumatol Oxf 43 389-390